First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers-Reference-Cited by-同舟云学术

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Published:2021-02 Issue:2 Volume:29 Page:611-625
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Komdeur Fenne L.,Singh Amrita,van de Wall Stephanie,Meulenberg Janneke J.M.,Boerma Annemarie,Hoogeboom Baukje Nynke,Paijens Sterre T.,Oyarce Cesar,de Bruyn Marco,Schuuring Ed,Regts Joke,Marra Ruben,Werner Naomi,Sluis Jessica,van der Zee Ate G.J.,Wilschut Jan C.,Allersma Derk P.,van Zanten Coba J.,Kosterink Jos G.W.,Jorritsma-Smit Annelies,Yigit Refika,Nijman Hans W.,Daemen Toos^ORCID

Funder

KWF Kankerbestrijding

European Regional Development Fund

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Self-replicating alphavirus RNA vaccines;Ljungberg;Expert Rev. Vaccines,2015

2. Alphavirus vectors for cancer therapy;Quetglas;Virus Res.,2010

3. Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapy;Riezebos-Brilman;J. Clin. Virol.,2006

4. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon;Liljeström;Biotechnology (N.Y.),1991

5. Two-helper RNA system for production of recombinant Semliki forest virus particles;Smerdou;J. Virol.,1999

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo;Molecular Therapy;2024-08

2. 1mΨ influences the performance of various positive-stranded RNA virus-based replicons;Scientific Reports;2024-07-31

3. Androgens in cervical cancer: Their role in epidemiology and biology;iScience;2024-07

4. Current status and future directions for the development of human papillomavirus vaccines;Frontiers in Immunology;2024-06-25

5. Targeting inflammation as cancer therapy;Journal of Hematology & Oncology;2024-03-22